PediRISE Feasibility
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 17
SponsorDana-Farber Cancer Institute
About this trial
The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a study about the PediRISE program, including a 50-50 chance of receiving standard usual care, and a 50-50 chance of receiving the PediRISE support program.
The names of the study groups in this research study are:
* PediRISE Program Group * Usual Care Group
Eligibility criteria
Qualifiers
Child diagnosed with de novo cancer
Child has established care at a study site and initiated cancer directed therapy in the prior 2-months
Child planned to receive at least 4-months of cancer-directed therapy at study site from time of diagnosis per initial cancer treatment plan
Child is <18 years at time of enrollment
Disqualifiers
Planned transfer of child to a non-DFCI or non-Columbia facility for cancer-directed therapy
Foreign national family receiving care as an Embassy-pay patient
Child is enrolled on embedded correlative health equity aims of open or upcoming clinical drug trials which are powered on descriptive parent-reported poverty data (e.g. AALL1731, DFCI 25-001). Co-enrollment on a poverty intervention study would confound the specified endpoints of these open trial correlative studies
Child or household member receiving SSI
Trial design
Treatments tested in this trial
- PediRISE Resource Program
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Dana-Farber Cancer Institute
Lead sponsor
American Cancer Society, Inc.
Collaborator
Children's Cancer Research Fund
Collaborator
Source ClinicalTrials.gov